Benzinga | Nov 5, 2021 09:22AM EDT

Codiak BioSciences Q3 EPS $(0.97) Up From $(12.83) YoY, Sales $1.16M Up From $954.00K YoY

Codiak BioSciences (NASDAQ:CDAK) reported quarterly losses of $(0.97) per share. This is a 92.44 percent increase over losses of $(12.83) per share from the same period last year. The company reported $1.16 million in sales this quarter. This is a 21.28 percent increase over sales of $954.00 thousand the same period last year.